Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
102 Cards in this Set
- Front
- Back
- 3rd side (hint)
Penicillin G
|
Class: Penicillin
Spectrum: Streptococci, Enterococci, Spirochetes Indications: Empirics for dental work, GAS/GBS, enterococci infection, syphillis, RMSF Mechanism: binds PBP; bacteriocidal Resistance: efflux, beta-lactamases, change target; in enterococci, pneumococcus, viridans Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Amoxicillin (PO)
Ampicillin (IV) |
Class: Penicillin
Spectrum: Penicillin G + H. flu, H. pylori, anaerobes, listeria Indications: head, mouth, gut, respiratory infections Mechanism: Binds PBP; bacteriocidal Resistance: efflux, beta-lactamases, change target Time dependent |
Spectrum
Indications Mechanism Resistance Pharmacodynamics |
|
Methicillin, naficillin, oxacillin, dicloxicillin (PO)
|
Class: Anti-staphylococcal penicillin
Spectrum: Staphylococcus Indications: Staph skin infection Mechanism: Mechanism: binds PBP; bacteriocidal Resistance: efflux, beta-lactamases, change target (MecA) Time dependent, short t1/2 |
Spectrum
Indications Mechanism Resistance Pharmacodynamics |
|
Ticarcillin, piperacillin
|
Class: Anti-pseudomonal penicillin
Spectrum: Pseudomonas aruginosa, Gram negatives - aerobic + anaerobic Indications: mixed nosocomial infections (aspiration pneumonia, intraabdominal...) Mechanism: binds PBP; bacteriocidal Resistance: Resistance: efflux, beta-lactamases, change target Time dependent |
Spectrum
Indications Mechanism Resistance Pharmacodynamics |
|
Cefazolin, cephalothin
|
Class: 1st gen cephalosporins
Spectrum: Gram + (staph, strep, enterococci) Indications: surgery prophylaxis, penicillin allergy Mechanism: bind PBP; bacteriocidal Resistance: beta-lactamases, altered target site Time dependent |
Spectrum
Indications Mechanism Resistance Pharmacodynamics |
|
Cefuroxime, cefoxitin, cefotetan
|
Class: 2nd gen cephalosporins
Spectrum: Gram +, some anaerobes, H. flu, enterococci Indications: soft tissue, bone infection, respiratory, intrabdominal Mechanism: Bind PBP, bacteriocidal Resistance: beta-lactamases, change target Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Ceftriaxone, ceftazidime
|
Class: 3rd generation cephalosporins
Spectrum: ceftriaxone: Gram + ceftazidime: pseudomonas and Gram negatives Indications: ceftriaxone: CSF G+ infection; ceftazidime: pneumonia, gonorrhea Mechanism: bind PBP, bacteriocidal Resistance: beta lactamases Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Cefepime
|
Class: 4th generation cephalosporin
Spectrum: Gram + and pseudomomas and some gram negatives Indications: nosocomial pneumonia Mechanism: 3rd gens combined Resistance: beta lactamases, altered target Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Imipenem, meropenem, ertapenem
|
Class: Carbapenem (B-lactam)
Spectrum: broadest of all NOT MRSA, listeria, enterococci Indications: resistant infections, penicillin allergy Mechanism: PBP binding, bacteriocidal Imipenem must be given with cilistatin Ertapenem is not for pseudomonas Resistance: efflux, altered PBP, carbapenamases, penicillin allergy Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Aztreonam
|
Class: Monobactam (B-lactam)
Spectrum: Gram negative aerobes No penicillin x-allergenicity Indications: penicillin allergy Mechanism: 4 membered ring, binds PBP, bacteriocidal Resistance: beta-lactamases, target site alteration Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Vancomycin
|
Glycopeptide
Gram + only (MRSA, C. difficile) Used in B-lactam allergy Prosthetic surgery prophylaxis, MRSA, enterococci, C. difficile Mechanism: binds D-ala subunit and does not allow x-linking Less bacteriocidal Resistance: some enterococci, staph. aureus, D-ala replaced by D-lac Time dependent Not removed by dialysis |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Bacitracin
|
Class: polypeptide
Binds undecaprenyl pyrophosphate so it can't carry cell wall precursors |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Levofloxacin
|
Class: Fluoroquinalone
Spectrum: Gram - , some Gram + (MRSA, pneumococcus), atypicals INTRACELLULAR BUGS Indications: UTI, GI infection, respiratory infection Mechanism: targets DNA gyrase and topoisomerase to prevent packaging of DNA Resistance: alter gyrase, topoisomerase, efflux Total area under the curve No surgical prophylaxis |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Moxyfloxacin
|
Class: Fluoroquinalone
Spectrum: Gram -, some gram +, atypicals, anaerobes INTRACELLULAR BACTERIA Indications: UTI,CA-pneumonia Mechanism: targets DNA gyrase and topoisomerase to prevent packaging of DNA Resistance: alter gyrase, topoisomerase, efflux Total area under the curve No surgical prophylaxis |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Ciprofloxacin
|
Class: Fluoroquinalone
Spectrum: Gram -, atypicals, pseudomonas INTRACELLULAR BUGS Indications: UTI, GI infection, HA-pneumonia, GNR osteomyelitis Mechanism: targets DNA gyrase and topoisomerase to prevent packaging of DNA Resistance: alter gyrase, topoisomerase, efflux Total area under the curve No surgical prophylaxis |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Rifampin
|
Class: Rifamycin
Spectrum: 1st line TB drug, mycobacteria, Gram +, Gram -, meningococcus, legionella, brucella Indicaions: always use in combination Penetrates biofilms!!!! Osteomyelitis, catheters Mechanism: binds B-subunit of RNA polymerase; bacteriocidal Resistance: Pol mutation |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Metronidazole
|
Spectrum: anaerobes below diaphragm, protazoa, C.difficle, H. pylori
Indications: bacterial vaginosis, colitis, botulism Mechanism: DNA strand breaking |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Daptomycin
|
Class: lipopeptide
Spectrum: Gram +, MRSA, enterococci Indications: vancomycin allergy/resistance Mechanism: Ca-dependent K+ permeability increase Bacteriocidal Not much resistance |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Colistin
|
Class: Polymyxin, Gram - only
Spectrum: pseudomonas Indications: old drug, highly toxic, so only for BAD infection Mechanism: intercalates into LPS membrane Resistance: little to none |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Erythromycin
|
Class: Macrolide
Spectrum: Gram +, atypicals (mycoplasma, chlamydia, legionella) Indications: Upper/lower RT, S. aureus skin infection, STDs USE IN PENICILLIN ALLERGY Respiratory and skin infection Mechanism: binds 50s ribosome Bacteriostatic Resistance: drug efflux, ribosomal methylation Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Clarithromycin
Azithromycin |
Class: Macrolide
Spectrum: Gram +, atypicals, plus H. flu, moraxalla, s. aureus, H. pylori Indications: Upper/lower RT, S. aureus skin infection, STDs Mechanism: binds 50s ribosome Bacteriostatic Resistance: drug efflux, ribosomal methylation Time dependent Give as Z-pack for sinuses, bronchitis, etc. |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Clindamycin
|
Class: Lincosamide
Spectrum: Gram + cocci only Used w/ cell wall drugs Also for toxoplasma, PCP Indications: above diaphragm infections (head, neck) Mechanism: Binds 50s ribosome; bacteriostatic Resistance: ribosome methylation, efflux Gives pseudomembranous collitis |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Linezolid
|
Class: Oxazolidine (NEW)
Spectrum: Gram +, MRSA, enterococci (can't get through gram negative membrane) RESISTANT DRUGS!!! Indications: Vanc resistance, allergy Mechanism: binds 50s ribosome Resistance: None Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Chloramphenicol
|
Gram + and Gram -
Indications: RMSF, meningitis, salmonella Limitations: aplastic anemia, vasomotor collapse Time dependent |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Quinupristin
Dalfopristin (Synercaid) |
Class: Streptogramins
Spectrum: MRSA, enterococci ONLY RESISTANT BACTERIA!!! Indications: old drug with high toxicity Mechanism: binds 50s ribosome Resistance: none Muscle aches, $$$$ |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Gentamycin, tobramycin, streptomycin, amikacin
|
Class: Aminoglycosides
Spectrum: Gram -, some gram + when used with cell-wall drugs Indications: unusual/nosocomial infections Mechanism: binds 30s ribosome; bacteriocidal IV ONLY! Resistance: enzymatic inactivation of drug Concentration dependent, low TI |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Doxycycline, tetracycline, minocycline
|
Class: Tetracyclines
Spectrum: Gram +, some gram -, atypicals, anti-malarial, good for vibrios Indications: CA-pneumonia, skin, soft tissue, STDs, lyme disease, MRSA, cholera Mechanism: binds 30s ribosome Bacteriostatic Resistance: photosensitivity, ribosomal methylation |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Bactrim
(TPM-STX) |
Class: Sulfonamides
Spectrum: NOT p. aeruginosa, anaerobes, mycoplasma Indications: CA-MRSA, UTI, resp. infection, brucellosis, ETEC, meningitis Mechanism: mimics PABA core Resistance: increased dihydrofolate reductase |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Isoniazid
|
1st line TB drug used with rifampin
Indications: active TB cornerstone Mechanism: inhibits mycolic acid synthesis; targets dividing cells Resistance: One in 1x10^6 bugs via mutation or catalase-peroxidase genes Pharmaco: metabolized by liver, so peripheral neuropathies and hepatitis GIVE WITH VITAMIN B6! |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Pyrazinamide
|
1st line mycobacterial drug
Unknown mechanism Metabolized in liver Resistance is rare Hepatitis |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Ethambutol
|
1st line mycobacterial drug
Bacteriostatic: inhibits arabinosyl transferase for cell-wall synthesis Rarely resistant: enzyme mutation Optic neuritis (color); neuropathy |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Streptomycin
Cycloserine PAS Ethinoamide Amikacin Capreomycin Moxiflocicin |
2nd line TB drugs
|
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
TB treatment guidelines
|
Start with INH, RIF, PZA, ETH
Wait for sensitivity results If sensitive to INH, RIF, drop PZA, ETH 4 drugs for 2 months 2 drugs for 4 months |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Acyclovir
|
Class: Anti-herpetic
Spectrum: HSV-1, HSV-2, VZV Indications: mild or disseminated, give 24-36 hrs in Mechanism: acyclic guanosine analog, phosphorylated by TK to bind DNA polymerase Resistance: TK deficiency |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Valacyclovir
|
Esterfied version of Acyclovir to make it more bioavailable
|
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Famciclovir
|
Anti-herpetic with mechanism like acyclovir
Esterfied pencyclovir for bioavailability |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Gancyclovir
|
Class: anti-herpetic
Spectrum: all herpesviruses Indicatons: CMV infection, retinitis IV only Resistance: UL97 protein kinase mutaton prevents phosphorylation in CMV Myelosupression |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Valgancyclovir
|
Esterfied gancyclovir
|
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Foscarnet
|
Class: anti-herpetic
Spectrum: all herpes viruses Indication: resistant infections Mechanism: inhibits DNA polymerase, no phosphorylation IV only, electrolyte disturbances |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Cidofovir
|
Class: Anti-herptic
Spectrum: all herpes, papilloma, pox viruses Indications: CMV retinitis Mechanism: nucleotide analog like HIV drugs, phosphorylated by cell kinases Nephrotoxicity, eye implant |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Rimantadine
Amantadine |
Class: anti-influenza
Spectrum: Influenza A Mechanism: blocks M2 protein preventing uncoating Resistance: commnn Leads to mental alteration |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Oseltamivir
(Tamiflu) |
Class: Anti-influenza
Spectrum: Influenza A, B Mechanism: NA inhibitor blocks viral release Resistance: recent!!! Given PO; Nausea and vomiting |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Zanamivir
(Relenza) |
Class: Anti-influenza
Spectrum: Influenza A, B Mechanism: NA inhibitor blocks viral release Resistance: recent!!! Inhaled mist; bronchospasm |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Ribavirin
|
Phosphorylated metabolite that blocks nucleic acid synthesis
Used in RNA and DNA viruses, especially RSV Used with INF-alpha against Hep C High toxicity |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
INF-alpha
|
Natural anti-viral peptide
Used with ribavirin for Hep C Sometimes used for Hep B Genital warts Papillomas in RT Gives flu-like symptoms since it's a natural inducer |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Enfuvirtide
(Fuzeon) |
HIV drug
Fusion inhibitor |
|
|
Maraviroc
|
HIV drug
CCR5 antagonist |
|
|
Vicriviroc
|
HIV drug
CCR5 antagonist |
|
|
Abacavir
|
HIV drug
NRTI Must be phosphorylated Hypersensitivity = flu-like |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Didanosine
|
HIV drug
NRTI Must be phosphorylated |
Class
Spectrum Indications Mechanism Resistance Pharmacodynamics |
|
Emtricitabine
|
HIV drug
NRTI Must be phosphorylated |
|
|
Lamivudine
|
HIV drug
NRTI Must be phosphorylated |
|
|
Stavudine
|
HIV drug
NRTI Must be phosphorylated |
|
|
Tenofovir
|
HIV drug
NRTI Must be phosphorylated |
|
|
Zidovudine (AZT)
|
HIV drug
NRTI Must be phosphorylated |
|
|
Nevirapine
|
HIV drug
NNRTI |
|
|
Delavirdine
|
HIV drug
NNRTI |
|
|
Efavirenz
|
HIV drug
NNRTI |
|
|
Etravirine
|
HIV drug
NNRTI |
|
|
Raltegravir
|
HIV drug
Integrase inhibitor |
|
|
Elvitegravir
|
HIV drug
Integrase inhibitor |
|
|
Atazanavir
|
HIV drug
Protease inhibitor |
|
|
Darunavir
|
HIV drug
Protease inhibitor |
|
|
Fosamprenavir
|
HIV drug
Protease inhibitor |
|
|
Indinavir
|
HIV drug
Protease inhibitor |
|
|
Lopinavir
|
HIV drug
Protease inhibitor |
|
|
Nelfinavir
|
HIV drug
Protease inhibitor |
|
|
Ritonavir
|
HIV drug
Protease inhibitor P450 inhbitor |
|
|
Saquinavir
|
HIV drug
Protease inhibitor |
|
|
Tipranavir
|
HIV drug
Protease inhibitor |
|
|
HIV treatment regimen
|
Begin treatment when CD4 count is below 350 or patient shows symptoms
Treat with 2 NRTI's + 1 NNRTI OR 2 NRTI + 1 protease inhibitor |
|
|
Amphotercin B
|
Class: Anti-fungal polyene
Spectrum: Broad Indications: deep seated infection Mechanism: Targets ergosterol Limitations: MANY toxicities due to cholesterol targeting ***Given within liposome to decrease toxitity |
|
|
Nystatin
|
Class:Polyene
Topical antifungal Binds ergosterol |
|
|
Miconazole (Monistat)
Clotrimazole |
Class: Azole
Spectrum: Skin fungal infections Mechanism: Inhibit funagl P450 to inhibit ergosterol synthesis Topical only (toxicities) |
|
|
Fluconazole
|
Class: Azole
Indications: Candida (C. krusi reistant), cryptococcus post-treatment, YEAST only!!! Mechanism: Inhibit fungal P450 PO/IV very bioavailable Penetrates BBB Watch for drug interactions |
|
|
Itraconazole
|
Class: Azole
Spectrum: Mycoses, toenails, aspergillus Mechanism: inhibits fungal P450 Lower BBB penetration, only IV Lots of drug interactions |
|
|
Voriconazole
|
Very broad antifungal
Inhibits fungal P450 PO/IV Gets everything with low side effects |
|
|
Posaconazole
|
Broad antifungal
Replacing Amphotercin B Active transport across GI, so PO Gets everything, bone marrow transplant prophylaxis ($$$) |
|
|
Flucytosine
|
Class: antimetabolite
Indications: cryptococcus with amphotercin B Mechanism: 5-fluorocytosine incorperated into RNA and binds polymerase Gives photopsia, rash |
|
|
Capsofungin
|
Class: glucan synthesis inhibitor
Mechanism: inhibits cell wall synthesis Good for candida |
|
|
Terbinafine (Lamisil)
|
Class: Allylamines
Inhibit ergosterol synthesis differently than azoles PO or topical River blindness or toenails Hepatobiliary dysfunction $$$$ |
|
|
Cryptococcus meningitis treartment
|
Flucytosine + Amphotercin B
THEN Fluconazole (BBB) - 8wks |
|
|
Broadest antifungals
|
Voriconazole, posconazole
Will get all candida strains Act by inhibiting P450 |
|
|
Chloroquine
|
Class: Anti-malarial
Spectrum: blood stages of plasmodium Mechanism: inhibits heme polymerase making toxic heme Resistance: mainly falciparum, drug efflux Weekly prophylaxis |
Class
Spectrum Mechanism Resistance Prophylaxis |
|
Mefloquine
|
Anti-malarial
Works on blood schizont stage only Works on chloroquine resistance Weekly prophylaxis Rare resistance in Thailand |
|
|
Atovaguone
Proguanil (Malarone) |
Schizont in blood and liver
Works against chloroquine resistance Prophylaxis for a few days |
|
|
Doxycycline
|
Anti-malarial
Erythrocyte stage only Use alone for prophylaxis Adjuvant to quinine Causes photosensitivity with other side effects |
|
|
Quinine
|
Anti-malarial
Erythrocyte stages only Rapidly cidal Not for prophylaxis Low TI - causes arrythmias, hypotension Rare resistance Adjuvant to doxycycline Only PO in US |
|
|
Quinidine
|
Anti-malarial
Rapidly cidal IV only Can cause arrhythmias, hypeotension |
|
|
Primaquine
|
Anti-malarial
Active against hypnozoite in liver (vivax and ovale) Daily PO Must test for G6PD deficiency! Terminal prophylaxis |
|
|
Uncomplicated malaria treatment
|
Chloroquine
OR Quinidine + doxycycline OR Mefloquine (1 dose) OR Malarone (1 dose) |
|
|
Complicated malaria treatment
|
IV quinidine + doxycycline
|
|
|
Vivax and ovale
|
Chloroquine
Can give primaquine |
|
|
Malaria prophylaxis with chloroquine resistance
|
Give weekly mefloquine,
daily doxycycline, daily Malarone, daily Primaquine |
|
|
Malaria prophylaxis without chloroquine resistance
|
Chloroquine weekly
|
|
|
Metronidazole and Iodoquinol
(Flagile) |
Class: Anti-ameoba
Spectrum: Flagile = tissue phase of amoeba (trophozoite)- not cysts Iodoquinol = cysts stage Indications: enterolytica, giardia, trichomonas, cryptosporidium |
|
|
Mebendazole
|
Class: Anti-helminthic
Spectrum: Most worms Indications: Pinworm Typically a single dose Few to no side effects |
|
|
Albendazole
|
Class: Anti-helminthic
Spectrum: Broad (including tapeworm) Mechanism: blocks worm's glucose uptake Single dose treatment |
|
|
Ivermectin
|
Class: Anti-helminthic
Spectrum: very broad, especially filaria, Norweigan scabies Limitations: flu-like symptoms with filarial infection |
|
|
Praziquantel
|
Class: Anti-helminthic
Spectrum: Blood flukes (schistosomiasis), also tapeworm Mechanism: cause calcium dependent K+ influx and paralysis of parasite Side effects: Dizziness, headache |
|
|
Iodoquinol
|
Anti-amoeba given with metronidazole
Kills amoeba in their cyst stage!!! |
|
|
Iodoquinol
|
Anti-amoeba given with metronidazole
Kills amoeba in their cyst stage!!! |
|